Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01064895 · ClinicalTrials.gov registry record
Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)
A clinical trial, sponsored by Angiodynamics.
- Terminated
- Registry status
NCT01064895: Clinical Trial study, sponsored by Angiodynamics.
NCT01064895 is a clinical trial that was terminated before completion, run by Angiodynamics. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01064895 was terminated before completion, sponsored by Angiodynamics.
- TERMINATED
- Registry status
Study Summary
This is a prospective, observational, multi-center study with consecutive enrollment. Up to 500 patients will be enrolled. All (consecutive) adult patients in whom one or more components of the Benephit Infusion System are planned to be used at participating sites are eligible for enrollment. The objective of this post-marketing surveillance study is to collect clinical usage patterns of the Benephit Infusion Systems. As a result, AngioDynamics will be able to (1) Better understand and quantify usage patterns including patient characteristics, adjunctive procedures, and infusion agents, (2) Collect user-interface information and overall customer satisfaction, and (3) Monitor post-marketing device performance and safety for ISO quality adherence.
Interventions
- DEVICE Benephit catheter for Targeted Renal Therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2010-02 |
| Est. Completion | 2011-12 |
Why NCT01064895 stopped before completion
NCT01064895 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Benephit catheter for Targeted Renal Therapy is the first listed.
NCT01064895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01064895 about?
NCT01064895 is a clinical study titled "Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)". This is a prospective, observational, multi-center study with consecutive enrollment. Up to 500 patients will be enrolled. All (consecutive) adult patients in whom one or more components of the Benephit Infusion System are planned to be used at participating sites are eligible for enrollment. The ob...
What is the current status of trial NCT01064895?
This trial is currently terminated. The study started on 2010-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01064895?
The interventions under investigation include: Benephit catheter for Targeted Renal Therapy (DEVICE).
Who is sponsoring clinical trial NCT01064895?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia